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ABSTRACT 
In his book “Medical Philosophy: Conceptual issues in Medicine“, Mario Bunge provides a unique 
account of medical philosophy that is deeply rooted in a realist ontology he calls “systemism”. 
According to systemism, the world consists of systems and their parts, and systems possess emergent 
properties that their parts lack. Events within systems may form causes and effects that are constantly 
conjoined via particular mechanisms. Bunge supports the views of the evidence-based medicine 
movement that randomized controlled trials (RCTs) provide the best evidence to establish the truth of 
causal hypothesis; in fact, he argues that only RCTs have this ability. Here we argue that Bunge 
neglects the important feature of patients being open systems which are in steady interaction with 
their environment. We show that accepting this feature leads to counter-intuitive consequences for 
his account of medical hypothesis testing. In particular, we point out that (i) the confirmation of 
hypotheses is inherently stochastic and affords a probabilistic account of both confirmation and 
evidence which we provide here; (ii) RCTs are neither necessary nor sufficient to establish the truth 
of a causal claim; (iii) testing of causal hypotheses requires taking into account background 
knowledge and the context within which an intervention is applied. We conclude that there is no 
“best” research methodology in medicine, but that different methodologies should co-exist in a 
complementary fashion. 
Keywords: Bayesianism; confirmation; evidence; evidence-based medicine; Mario Bunge; 
systemism; systems thinking; philosophy of medicine; philosophy of science 
 
1. Introduction 
In his book „Medical Philosophy: Conceptual issues in Medicine“ the scientist and philosopher 
Mario Bunge contrasts what he calls “scientific medicine” with complementary and alternative 
medicine (CAM)
1
 which according to him “is a broad panoply of therapies lacking in both scientific 
basis (knowledge of mechanism) and evidence (randomized controlled trials)” [1]. His distinction 
between these two types of medicine is not only epistemological (according to him only scientific 
medicine has knowledge of mechanisms and is evidence-based), but also an ontological one (that 
                                                             
1 Bunge makes no further distinction between traditional, complementary and alternative medicine which is 
problematic, since all three refer to different concepts of medical systems. However, a detailed criticism of this 
conflation is not our concern here. 
refers to the some features of the world): While he perceives CAM embedded in a holistic worldview 
(“the hole precedes and dominates its parts”), scientific medicine “treats patients like … systems that 
can be dismantled, at least conceptually, with the help of modern biology: it is systemic.” 
Bunge’s ontological characterization of modern medicine as systemic follows his earlier work on 
the philosophy of social science. It is not found within other books on the philosophy of medicine [2–
5]. It therefore deserves a critical appraisal, in particular concerning its implications for epistemology 
and medical research praxis (methodology). This is what we aim for in this paper. We are thereby not 
concerned with his philosophy of medicine as such, but with the broader implications that emerge 
from his realist-systemic ontology concerning emergence of new properties not reducible to some 
more fundamental properties and evidence. We agree that such an ontology seems indeed quite 
reasonable given the successful history of systems thinking in biology and its increasing applications 
in medicine [6–8]. However, there is a lack of meta-research on the implications of systems thinking 
for the hallmarks of modern medicine such as randomized controlled trials (RCTs) and evidence-based 
medicine (EBM) in general. 
In the next section, we first provide a motivation for systems thinking and anti-reductionism in 
medicine and then describe Bunge’s account of systemism in medicine that adopts the Humean 
conception of causality in which cause and effect are constantly conjoined. In section 3, we will 
review Bunge’s epistemological principles for good scientific practice in medicine, and relate it to the 
current paradigm of EBM. We are going to highlight that both Bunge and EBM emphasize a 
hierarchical structure of medical evidence and research methodologies, with RCTs conceived as 
providing the highest quality evidence for establishing the truth of medical hypotheses. In section 4 we 
are going to develop our critique of Bunge’s conception of causality based on the argument that 
humans are not closed, but open systems which are in steady interaction with their environment. The 
acceptance of this fact is at odds with both a constant conjunction of events and the proposition of a 
hierarchy of methodologies with RCTs on top. Instead, we argue for a “circular” or integrative view of 
evidence in which multiple methodologies co-exist with each other and the best method is dependent 
on the particular context and research question.  
2. Systemism, emergence and medicine 
2.1. Background 
The view that every medical phenomenon can be explained by referring to entities at a lower 
ontological level, also called entity reductionism, appears to be the default view in medicine [3, 
chapter 4]. Examples abound: Diseases are reduced to their syndromes which are treated by 
pharmaceutical drugs; individual biomarkers which lie outside their normal range are “corrected” 
without considering system-wide effects [6]; tumors are mostly conceived as independent entities and 
ultimately reduced to the level of oncogenic driver mutations or tumor suppressor loss-of-function 
mutations for which targeted therapies could be designed – which is then called “precision medicine”; 
humans with a disease are reduced to patients instead of also being agents (capable of taking actions 
by themselves) [9]. Finally, a reductionist view may also be held responsible for the “junk science” 
produced within the field of nutrition research where dietary complexity and that of the person or 
animal eating the diet are all too often reduced to associations of single macro- and micronutrients 
with certain outcomes, leading to false and sometimes counter-intuitive conclusions [10,11]. 
Such reductionism in medicine is challenged from a biological perspective considering that 
macroscopic multicellular life possesses a kind of complexity that cannot be solely explained through 
the properties of its constituent parts. Bains and Schulze-Makuch for example, by comparing a fruit fly 
to an equivalent mass of Escherichia coli (E. coli), write: 
The mass of E. coli can be described by describing one E. coli and then saying “grow 109 of 
them”, [while] describing a fruit fly requires describing all of its cell types and their 
interactions in chemistry, space and time [12]. 
This example highlights Bunge’s conception of emergence. The fruit fly possesses certain 
properties that none of its constituents possesses, e.g. sexuality. These are emergent properties [13]. In 
contrast, the conglomerate of E. coli bacteria lacks any special property that would not also be 
possessed by an individual E. coli bacterium, and hence has no emergent properties. More generally, 
Bunge defines emergent properties as systemic properties that none of the parts of the system share, 
but that are explainable by the parts of the system and its entire organization [13]. In other words, 
according to him, certain systemic properties are ontologically emergent properties, and are not 
anyway reducible to some more basic properties. Insofar, he is an ontological anti-reductionist. He 
thinks, however, that every system with emergent properties can be explained by our knowledge about 
its lower-level properties and their connections. Thus, he is an epistemological reductionist. Bunge 
calls his stance rational emergentism. In his view, every aspect of the fruit fly within a given context 
should be principally explainable if all of the fly’s constituents plus all their interactions within this 
context would be known. Since diseases can be conceptualized as emerging properties of individual 
patients, scientific medicine should aim at understanding (i) the underlying properties that give rise to 
a disease; (ii) their interaction with the environment; (iii) their manipulation through medical 
interventions. Our argument, developed in more detail below, will be that the second point is strongly 
neglected in Bunge’s account of medical hypothesis testing. 
2.2. Bunge’s ontological systemism 
Bunge’s systemism is influenced by Paul Henri Thiry d’Holbach’s Système de la Nature 
(published in 1770) and Ludwig von Bertalanffy’s General System Theory [14]. For Bunge, the world 
is an objective reality made up of systems or parts thereof and therefore stratified into different levels 
or “layered”. This is the ontology he refers to as “systemism”. In more detail, his systemic worldview 
rests on the following two postulates, stated in an earlier paper [15]: 
(S1) Everything, whether concrete or abstract, is a system or an actual or potential component of a 
system; 
(S2) Systems have systemic (emergent) features that their components lack. 
Bunge argues that “systemism is the only ontology that fits the modern sciences” and that, 
“because it entails emergentism, systemism overcomes reductionism in its various forms” (p.15).2 He 
emphasizes that systemism entails ontological emergence since systems are postulated to possess 
properties that only emerge from the interaction of their parts. As examples for such emergent 
properties within medicine, Bunge names apoptosis on the level of cells (p. 138) or being alive, 
thinking and socializing (p.16) on the level of the whole system.  
Bunge classifies systems broadly into being concrete/material (stars, cells, humans, social 
systems etc.) or abstract (properties, events, ideas, feelings etc.). Concerning the former he writes [1, 
pp.13-14]: 
The conceptual or empirical analysis of a concrete system, from atom to body to society, 
consists in identifying its composition, environment, structure, and mechanism. These 
components may be schematically defined as follows: 
Composition = Set of constituents on a given level (molecular, cellular, etc.) 
Environment = Immediate surrounding (family, workplace etc.) 
                                                             
2 Bunge speaks of emergentism instead of emergence as in his former publications.  
Structure = Set of bonds among the components (ligaments, hormonal signals, etc.) 
Mechanism = Process(es) that maintain(s) the system as such (cell division, metabolism, 
circulation of the blood, etc.) 
Bunge defines the environment of a system as the set of all entities not being part of the system, 
but interacting with it. He generally conceives causal mechanisms as processes (sequences of events) 
in concrete systems involving energy transfer that are activated by particular events (the causes) 
[16,17]. Mechanisms can act between different levels of a system in both top-down and bottom-up 
direction (Figure 1). Bunge adopts the Humean view of causation − event X is a cause of event Y if 
and only if (i) X is both a necessary and sufficient condition for Y to happen, and (ii) X happens 
before or simultaneously with Y. In this sense, mechanisms act as mediators between causes and their 
effects. 
While Bunge mentions the importance of the (social) environment and its interaction with 
patients, he makes no distinction between open and closed systems in his medical philosophy. This is 
despite the concept of an open system as “the characteristic state of the living organism” having been 
introduced by von Bertalanffy [14] who is cited as an influencer of systemism in Bunge’s book. 
According to von Bertalanffy, an open system is characterized by a “steady inflow and outflow of 
materials” [14]. Contrary to closed systems, open systems therefore transcend both conventional 
thermodynamics and one-way causality of the form “this one event always causes this or that effect” 
[18]. We more generally conceive an open system as a system which is in steady interactions with its 
environment, whereby these interactions can give rise to events and the triggering or avoidance of 
mechanisms; they hence influence causal effects. As we will argue in section 4, Bunge’s failure to 
clearly characterize patients as open systems is the major flaw in Bunge’s medical philosophy, giving 
rise to several epistemological and methodological problems in his account. 
 
 
Figure 1. Two examples for mechanisms acting across levels in top-down or bottom-up direction. In 
the former case, macrosocial factors such as unemployment or gender discrimination induce chronic 
stress in affected individuals which in turn negatively affects gene transcription through epigenetic 
modifications. Such modifications of gene transcription can promote the development of systemic 
diseases such as (type II) diabetes which in turn has negative effects on the social level by decreasing 
productivity or inflicting additional costs to the health care system. These examples are taken from 
page 35 of Bunge’s book [1]. 
3. Bunge’s epistemology 
Bunge’s epistemological principles for scientific medicine can best be summarized by three 
further postulates that he stated in a previous paper along with the two ontological postulates cited in 
the previous section [15]:  
(S3) All problems should be approached in a systemic rather than in a sectorial fashion; 
(S4) All ideas should be put together into systems (theories); and 
(S5) The testing of anything, whether idea or artifact, assumes the validity of other items, which are 
taken as benchmarks, at least for the time being. 
According to Bunge, and in line with several other philosophers of science, biomedical research 
is particularly concerned with the testing of causal hypotheses
3
 Causal hypotheses require causal 
mechanisms which may be conjectured based on statistical data (e.g. observational studies) [1,16]. 
Bunge has a Humean conception of causality in which cause and effect are constantly conjoined. Such 
conception was once the standard view in medicine. It was first questioned in the 1950s when the 
problem whether smoking causes lung cancer was being investigated more thoroughly [5]. Smoking is 
neither necessary (asbestos, e.g., can also cause lung cancer) nor sufficient (not every smoker gets lung 
cancer) for lung carcinogenesis. This example clearly showed that there could be causes that are not 
always followed by their effects; it required a new concept of causality called indeterministic or 
probabilistic causality and spurred new philosophical investigations of the link between causality and 
probability that last until today [5]. Bunge, however, rejects any fundamental connection between 
causation and probability. On Bunge’s account, probability measures the objective possibility or 
likelihood of an individual fact, but only when there is chance involved, either within things 
themselves (atoms) or the sampling procedure that determines the observation of the facts 
(randomization). He therefore rejects Bayesianism in its broadest sense which he accuses of being 
subjective, absurd and even dangerous when applied to diseases and therapy [1, p. 101].
4
 We are going 
to discuss the AIDS example which he uses to justify this claim in the next section. 
The adoption of causal determinism and abandonment of probabilities
5
 characterize his account of 
medical hypothesis testing and his concepts of evidence and confirmation. For Bunge, it is necessary 
to subject medical hypotheses to tests of two kinds − a conceptual test according to his postulate (S5), 
evaluating whether the hypothesis is consistent with the bulk of prior knowledge; and an experimental 
test that can only be conducted through a randomized controlled trial (RCT). Bunge conceives 
randomization into a treatment and control group necessary to correct for biases that are due to the 
heterogeneity of human individuals. Only randomization could guarantee an equal distribution of all 
unknown variables with a possible influence on the outcome between treatment and control group, “so 
that the intervention stand out as the only cause of the difference in the outcome of the study” [1, p. 
142]. 
This argument echoes the one made by the evidence-based medicine (EBM) movement that has 
always considered RCTs as the “gold standard” providing the best available evidence, because only 
RCTs would theoretically balance any unknown factors between treatment and control group 
confounding the association between an intervention (the cause) and its effect. Hence, RCTs (and their 
meta-analyses) were conventionally placed on top of the so-called “evidence hierarchy”, in which non-
randomized trials and observational studies are graded with much lower evidence quality [19]. We 
agree with EBM proponents who claim that “the higher the quality of evidence, the closer to the truth 
are estimates of diagnostic test properties, prognosis, and the effects of health interventions” [19]; 
however, if high quality evidence is set equivalent to particular quantitative research methods 
generating the evidence as suggested by various EBM “evidence hierarchies”, this amounts to 
embracing a positivist-empiricist philosophy.
6
 Such reasoning has evoked much criticism from both 
medical practitioners [20–23], methodologists and philosophers of science [24–30]. 
                                                             
3 He broadly distinguishes three kinds of causal hypotheses: (i) Null hypotheses of no association between two 
putatively causally connected variables. (ii) General hypotheses of the form “X is a cause of that disease” or “the 
mechanism of X is Y”. (iii) Particular hypotheses such as “that individual is likely to suffer from that disease”. 
 
4 This sounds like an argument by definition. Bunge postulates a meaning for “probability” and then concludes 
that the Bayesian conception is absurd. However, we are not going to pursue this point further here. 
5 Bunge seems to have missed that Bayesians of the personalist stripe are ontological determinists and epistemic 
probabilists. 
6 We use the term positivist-empiricist referring to a conjunction of concepts of logical positivism and Humean 
empiricism. The former rejects any reference to unobservable (metaphysical) entities, while the latter describes 
 Figure 2. Bunge’s “biomedical research rigor” hierarchy. Such a pyramid is the stereotype of an 
”evidence hierarchy” widely promoted especially in the early phases of the EBM movement [19]. 
Bunge rejects most of the criticisms against the evidence hierarchy and “uphold[s] the ruling 
opinion that the RCT is the gold standard of biomedical research [since] it is the most objective and 
impartial, hence also the most reliable and responsible, method for assessing the effectiveness of 
medical interventions on members of heterogenous populations” [1,page 149]. According to Bunge, 
RCTs are necessary, although not sufficient, to establish the truth of a medical hypothesis. They are 
insufficient because they overlook mechanisms of action. Therefore, Bunge proposes a new pinnacle 
of the methodological hierarchy (the “platinum standard”) consisting of (i) double-blind and placebo-
controlled RTCs with (ii) the explicit statement of a mechanism of action which can account for the 
observed associations (Figure 2). The order below his supposed platinum standard is analogous to the 
traditional EBM evidence pyramid in that it ranks evidence from RCTs higher than that from non-
RCTs (e.g. case-control or cohort studies) which in turn deliver evidence that is ranked higher than 
that from case series and case reports. Through his emphasis on evidence for mechanisms contributing 
to the platinum standard, Bunge departs from EBM in which studies providing evidence for 
mechanisms are ascribed the lowest quality at the bottom of the various evidence hierarchies [31]. In 
this way he attempts a rationalism-empiricism synthesis that “is fruitful only jointly with realism” [1, 
p. 81]. However, Bunge’s views on the epistemological merits of research methodologies below RCTs 
appear even more extreme than those of EBM; he simply denies that they have any power for testing 
causal hypotheses: 
[O]nly RCTs allow researchers to find out whether a medical treatment is effective. (If 
preferred, this method is used to find out whether propositions of the form “This therapy is 
effective” are true or false.) [1, p. 143] 
                                                                                                                                                                                              
the scientific endeavor to test causal hypotheses by finding quantitative associations between observed events. 
Indeed, the literature on the philosophical and methodological foundations of EBM emphasizes statistical 
methodologies and avoids any reference to a particular ontology [2,19]. 
Bunge uses the word “true” referring to the concept of factual truth that he sharply distinguishes 
from probability. For him, truth is a property of propositions such as hypotheses, while probability is a 
property of individual random facts (“things and events out there”, p. 99) and therefore ontological. 
Truth values measure the degree to which a hypothesis corresponds to the facts and are measured by 
conducting experiments. In contrast, probability values are theoretically assumed, guessed or 
calculated by frequencies, but never directly measured. Hence, it is not the goal of RCTs to estimate 
probabilities of individual facts, but rather to estimate truth values of hypotheses. Concerning the 
assignment of such truth values to scientific hypotheses Bunge writes: 
The aim of an experiment, contrary to that of an observation or a measurement, is to garner 
empirical data relevant to a hypothesis, to test it and find out its degree of factual (or 
empirical) truth (true, true within such an error, or false). When there is a theory 
(hypothetico-deductive system of propositions) referring to the same facts, the hypothesis 
that undergoes an empirical test can also be assigned a theoretical truth value. In both cases, 
the truth in question is factual, not formal or mathematical [1, page 131]. 
Therefore, according to Bunge, it is empirical data stemming from an experimental study and 
being relevant to a hypothesis that are necessary for both testing the hypothesis and assigning it a truth 
value. Such data then become evidence: 
A datum becomes evidence when confronted with a hypothesis: in this case it either 
confirms or weakens the hypothesis to some extent [1, page 28]. 
Thus, in Bunge’s view data that are relevant to a hypothesis are evidence for the hypothesis and 
simultaneously confirm/disconfirm and assigns a truth value to it. However, Bunge gives no 
unequivocal answer to the question of how exactly a causal hypothesis is supposed to be confirmed or 
refuted. On one occasion he claims that “[o]nly the unveiling of a mechanism can confirm or refute a 
causal guess” (p. 100), while on another occasion he states that “confirming or refuting a causal 
hypothesis, is what is gained when one subjects it to a controlled experiment” (p. 155). We will show 
in section 4 how the important role of both mechanisms and statistical data for confirming a causal 
hypothesis follows naturally from a Bayesian analysis of causal hypotheses. We also show how a 
conceptual distinction between evidence and confirmation is helpful to understand scientific inference 
including inference in the medical sciences. In contrast to Bunge’s description of medical hypothesis 
testing, our concepts of evidence and confirmation are able to account for prior knowledge, 
uncertainties in inference and the objective comparison between different hypotheses based on 
observed data. 
4. A critique of Bunge’s medical philosophy 
Having reviewed the ontological and epistemological principles of Bunge’s medical philosophy, 
which heavily rests on his general account of systemism, we are now going to formulate our major 
critique against Bunge’s account: 
Humans are open systems ⇒ 
(C1) The confirmation of hypotheses is inherently stochastic and must be distinguished from the notion 
of objective truth; only comparisons between hypotheses in light of background knowledge and their 
ability to explain the observed data are objective 
(C2) RCTs are neither necessary nor sufficient to establish the truth of a causal claim 
(C3) Testing of causal hypotheses requires taking into account background knowledge and the context 
within which an intervention is applied 
In the following three subsections we will justify our claims (C1) to (C3) in more detail. 
4.1. Evidence and confirmation as separate concepts 
According to von Bertalanffy, who is cited in Bunge’s book as a pioneer of systemism, every 
living system is an open system [14,18]. In system terms, open systems are characterized by steady 
interactions between the different components of the systems, the systems as a whole with their 
components and the systems and their components with other systems and their components in the 
environment. These interactions would give rise to events and hence causality, because interactions 
represent causal relationships between events; however, they are so complex and dynamic that 
causality cannot be considered as a constant conjunction of events. That would only be the case in 
closed systems, something that can be only be established artificially through particular experimental 
setups in some natural sciences such as physics. In natural open systems, however, causality arises 
from a tendency on behalf of the system to produce certain patterns or regularities under particular 
contexts [32]. As a consequence, there are no universal regularities of the form “whenever event X, 
then event Y”, only what appear as such on average and what Lawson has named “demi-regularities”. 
Conceptualizing humans as open systems, it becomes clear that the same medical intervention applied 
in different study settings not always leads to the same outcome since the outcome depends on the 
environment/ context in which it occurs. It is crucial to point out that statistical methodologies not 
only presuppose, but only work in closed systems if the goal is to establish causality [33]. One must 
therefore accept that variations in regularity are predicted to occur in experimental studies in biology, 
medicine and sociology. This will require the utilization of probabilities: 
Variations in regularity are generally specified probabilistically or stochastically, as random 
processes occurring in the ontic domain. Probability is a measure of the likelihood of an 
event occurring. The re-conceptualization of stochastic event regularities using the concepts 
of probability, might be styled ‘whenever event x, then on average event y’ [33]. 
For realists, the truth of causal hypotheses cannot be established in an objective way through 
statistical data alone due to the unavoidable limitations of experiments conducted on biological open 
systems, or in other words the impossibility to achieve complete closure of a biological open system in 
order to nail down the true causal effect of an intervention. It follows that the confirmation or 
disconfirmation of a hypothesis by statistical data is not about assigning (objective) truth values as 
Bunge claims, but about raising or lowering an agent’s (subjective) belief in the truth of the 
hypothesis. Once framed, a realist will seek to scrutinize a causal hypothesis in further tests which 
hopefully provide stronger and stronger confirmation of it [32]. At the same time, the realist will 
consider different competing hypotheses/models about the data-generating causal processes that she 
attributes to different entities that are or may be real; the data may then decide between these 
hypotheses in an objective way.  
We have developed two distinct Bayesian accounts to capture these two concepts about the 
testing of statistical hypotheses [34,35]. The first is an account of belief/confirmation, the second of 
evidence. Many Bayesians interpret confirmation relations in various ways. For us, an account of 
confirmation explicates a relation, C(D,H,B) among data D, hypothesis H, and the agent’s background 
knowledge B. For Bayesians, degrees of belief need to be fine-grained. A satisfactory Bayesian 
account of confirmation, according to us, should be able to capture this notion of degree of belief. In 
formal terms:  
D confirms H to some degree if and only if P(H|D) > P(H) 
The posterior/prior probability of H could vary between 0 and 1. Confirmation becomes strong or 
weak depending on how great the difference is between the posterior probability, P(H|D), and the prior 
probability of the hypothesis, P(H). P(H|D) represents an agent’s degree of belief in the hypothesis 
after the data are accumulated.
7
 P(H) stands for an agent’s degree of belief in the hypothesis before the 
data for the hypothesis have been acquired. The likelihood function, P(D|H), provides an answer to the 
question “how likely are the data given the hypothesis”? P(D) is the marginal probability of the data 
averaged over the hypothesis being true or false. The relationships between these terms, P(H|D), P(H), 
and P(D|H), and P(D) are succinctly captured in Bayes’ theorem:  
P(H|D) = P(D|H)×P(H)/P(D) > 0. 
While this account of confirmation is concerned with belief in the truth of a single hypothesis, our 
account of evidence compares the merits of two hypotheses, H1 and H2 (which could be ¬H1) relative 
to the data D, auxiliaries A, and background information B. We conceive the evidence of one 
hypothesis versus the other as an objective function of the data generating process
8
, which takes place 
via observed or unobserved mechanisms within the system under study. This is also how 
Bandyopadhyay, Brittan and Taper interpret the likelihood that determines the evidence [35, p.30]: 
It is natural to assume that the “propensity” of a model to generate a particular sort or set of 
data represents a causal tendency on the part of natural objects being modeled to have 
particular properties or behavioral patterns and this tendency or “causal power” is both 
represented and explained by a corresponding hypothesis.  
As such, evidence provides the link between “the Real” about which we construct hypotheses and 
“the Empirical” which we observe as patterns or regularities.9 Our concept of evidence is therefore 
consistent with a realist-systemic ontology. Note that this concept also fulfills Bunge’s postulate (S5) 
by explicitly taking background knowledge into account. Such background knowledge and auxiliaries 
allow deriving evidence through a variety of methodologies, as long as the data are relevant to an 
aspect of the hypotheses being compared. For example, observing a high correlation between 
treatment X and effect Y in a RCT may in theory provide the strongest evidence for the claim that X 
causes Y when the alternative is that X is no direct cause of Y, but X and Y are correlated because 
both are caused by some third (confounding) factor. In contrast, a single case report of a patient taking 
a drug and developing a serious side effect together with background knowledge about the biological 
actions of the drug may provide strong evidence for the hypothesis that the drug is harmful in 
particular contexts.
10
 Finally, preclinical in vitro and in vivo studies may provide strong evidence in 
favor of a particular mechanism underlying an observed correlation between treatment and outcome.  
Because evidence is not a belief relation, but a likelihood ratio, it need not satisfy the probability 
calculus. The data D constitute evidence for H1&A1&B against H2&A2&B if and only if  
[P(D|H1,A1&B)/ P(D|H2,A2&B)] > 1. 
Bayesians use the Bayes factor (BF) to make this comparison, while others use the likelihood 
ratio (LR) or other functions designed to measure evidence. For simple statistical hypotheses with no 
                                                             
7 More precisely, we can speak of the degree of belief in the truth of the hypothesis; this unifies Bunge’s 
arguments about hypotheses being confirmed and hypotheses being assigned truth values.  
8 The data generating process is covered by the auxiliary hypotheses which can be about mechanisms. These 
auxiliaries serve as links between theoretical entities of the system under study and observable features in nature, 
in this way generating observable predictions [51]. 
9 The distinction between the Real and the Empirical is borrowed from Critical Realism which itself exhibits many 
features of systems thinking [50]. 
10 An example is a recent case report of a patient with chronic kidney disease experiencing severe lactic acidosis 
from taking the widely prescribed anti-diabetic drug metformin [52]. In the case report, the authors state their 
background knowledge as follows: “In the setting of dehydration with resultant acute kidney injury, metformin 
can accumulate, leading to type B lactic acidosis, especially in the presence of other nephrotoxic agents (ACEi and 
loop diuretics)”. They conclude to “use this patient as an example of the population that actually needs dosing 
adjustments”, a theoretical generalization supported by the evidence obtained from observations on this single 
patient. 
free parameters, the Bayes factor and the likelihood ratio are identical, and capture the bare essentials 
of an account of evidence without any appeal to prior probability. However, the LR becomes an 
inadequate measure of evidence whenever there are free parameters to estimate; the greater the 
number of parameters, the more biased the LR becomes. This is what information criteria such as AIC 
or BIC try to account for [36]. For hypotheses under which there are unknown parameters θ, the 
densities
11
 P(D|H,A&B) are obtained by integrating over the parameter space, so that  
P(D|H,A&B) = ∫P(D|θ,H,A&B)π(θ|H,A&B)dθ [37]. 
An immediate corollary of the evidential condition (E) is that there is equal evidential support for 
both hypotheses only when BF=1 (or LR=1). The numerical value of the BF or LR which 
distinguishes weak from strong evidence for H1 versus H2 is determined contextually and may vary 
depending on the nature of the problem. It also follows that evidence is accompanied by confirmation 
and vice versa in the special case that two hypotheses are mutually exclusive and jointly exhaustive. In 
this case, if the data provide evidential support for H against ¬H, i.e. P(D|H) > P(D|¬H), then it 
follows from Bayes’ theorem that P(H|D) > P(H). However, even in this case a hypothesis for which 
the evidence is very strong may not be very well confirmed while a claim that is very well confirmed 
may have no more than weak evidence going for it [35, p.38]. Finally, we note that in many scientific 
studies, no precise quantitative determination of likelihoods, priors and posteriors of hypotheses might 
be possible. Even then our concepts remain useful for making qualitative or comparative statements 
about hypotheses. For example, a qualitative evidential statement may be “the data provide 
more/equal/less evidence for H1 compared to H2”; a comparative statement relating to confirmation 
may be “H1 is better confirmed/equally confirmed/less confirmed by the data than H2”.12  
We will now demonstrate the usefulness of our confirmation/evidence distinction using an 
example provided by Bunge himself, the purpose of which was supposed to reject Bayesianism as 
unreasonable [1]: 
It is well known that HIV infection is a necessary cause of AIDS: no HIV, no AIDS. In other 
words, having AIDS implies having HIV, though not the converse. Suppose now that a given 
individual b has been proved to be HIV-positive. A Bayesian will ask what is the probability 
that b has or will eventually develop AIDS. To answer this question, the Bayesian assumes 
that the Bayes’ theorem applies, and writes down this formula: P(AIDS|HIV)=P(HIV|AIDS). 
P(AIDS)/P(HIV), where an expression of the form P(A) means the absolute (or prior) 
probability of A in the given population, whereas P(A|B) is read (or interpreted) as “the 
conditional probability of A given (or assuming) B.” 
If the lab analysis shows that b carries the HIV, the Bayesian will set P(HIV)=1. And, since 
all AIDS patients are HIV carriers, he will also set P(HIV|AIDS) = 1. Substituting these 
values into Bayes’ formula yields P(AIDS|HIV) = P(AIDS). But this result is false, since 
there are persons with HIV but no AIDS. What is the source of this error? It comes from 
assuming tacitly that carrying HIV and suffering from AIDS are random facts, hence subject 
to probability theory. The HIV-AIDS connection is causal, not casual; HIV infection is only 
a necessary cause of AIDS. In conclusion, contrary to what Bayesians (and rational-choice 
theorists) assume, it is wrong to assign probabilities to all facts. Only random facts, as well 
as facts picked at random, have probabilities. 
                                                             
11 These probabilities of the data are also known as marginal or integrated likelihoods; some authors also denote 
them as “evidence” [e.g., 53,54], which must not be confused with our account of evidence that always implies a 
comparison between two competing simple statistical hypotheses. 
12 See Klement [55] for such a qualitative medical application of the evidence/confirmation distinction. 
The example is supposed to show a paradox arising from Bayesian reasoning. The paradox is that 
a positive HIV test result provides no confirmation for the hypothesis AIDS, i.e., that b has or will 
develop AIDS, since the posterior probability of AIDS after obtaining a positive test result is the same 
as its prior probability. However, the paradox only arises because Bunge is wrong in two assumptions: 
First, that a positive test result is “true”, so that P(HIV)=1, and second that the test has perfect 
sensitivity, so that P(HIV|AIDS)=1. Both assumptions are at odds with realistic assumptions about 
tests on open systems which are never perfect. Regarding Bunge’s first assumption, he mistakenly 
identifies “knowing or observing the data” with “the probability of the data” [35, p.137]. For a 
Bayesian realist the positive test result is the realization of some data generating mechanisms (in this 
case, mechanisms of the disease AIDS) modelled by a binary random variable taking on the value of 
either 0 or 1, so that the correct way of writing P(HIV) is 
P(HIV=1)=∑P(HIV=1|Hi)P(Hi)=P(HIV=1|AIDS)P(AIDS)+P(HIV=1|¬AIDS)P(¬AIDS). 
This expression includes both the true positive rate (sensitivity) and false positive rate (1- 
specificity) none of which are exactly 100% or 0%, respectively, in medical tests. In this specific 
example, the assumptions P(HIV|AIDS)≈1 and P(HIV|¬AIDS)≈0 can indeed be justified based on 
generally very high sensitivity and specificity of HIV tests (although there is clear variation in these 
test performances across different settings [38], emphasizing the importance of environment/context). 
However, the prior probability of b having or not having AIDS before the test result is known is also 
important. In general, observing HIV is the case does not therefore imply P(HIV)=1.  
On our account, a positive test indeed provides strong evidence for the AIDS hypothesis because 
P(HIV|AIDS)≫P(HIV|¬AIDS). In accordance with our intuition, this does not depend on our prior 
beliefs about the person having or not having AIDS in the first place. What we should believe about b 
having AIDS after the positive test result has been obtained is however a different question, and again 
in accordance with our intuition, the answer to this question should now depend on the context, e.g. 
what we know about the individual and its social relationships. Bunge is not able to capture these 
intuitions.  On his account, solving the inverse problem of going from the results of a medical test or 
some sign S of a disease D to the precise diagnosis of D can only be achieved if there is a single 
mechanism M that when conjoined with S is necessary and sufficient for D to occur. In the AIDS 
example above his reasoning goes as follows: AIDS occurs ⟺ HIV infection & slow immune reaction, 
where slow immune reaction describes the mechanism by which HIV leads to immune system failure. 
More generally his reasoning is (p. 88): 
For all x: (Dx ⟺ Mx) & For all x: (Mx ⟺ Sx) ∴ For all x: (Dx ⟺ Sx) 
Bunge’s solution presupposes that the mechanisms causally linking the signs and the disease 
always operate the same way, regardless of the context. In other words, he presupposes a closed 
system, which is not even approximately the case given that medical tests have sensitivities and/or 
specificities varying across contexts and often less than 100%. 
Bunge simply fails to realize that medical (as well as biological and social) observations are never 
“facts” because we deal with open and systems and hence uncertain inferences. 
4.2. RCTs and the truth claim 
We are now investigating Bunge’s claim that RCTs are necessary to infer the truth of a causal 
hypothesis in more detail. To this aim, it is helpful to first review some methodological principles of 
RCTs. A good overview has recently been provided by Deaton and Cartwright [27], and we follow 
their account to a large extent. Without loss of generality we assume that the medical hypothesis to be 
tested in a RCT is a proposition of the form “treatment T is effective” the truth of which is typically 
assessed by measuring some particular outcomes in the randomly allocated treatment and control 
groups. To measure the truth of a medical hypothesis then means to measure the true average 
treatment effect (ATE) of the intervention, where the ATE is the difference between the average 
outcome in the treatment group and the average outcome in the control group.
13
 Assuming a linear 
causal model for the individual treatment effects one could write for an individual outcome 




Here 𝑌𝑖 is the outcome for patient 𝑖, 𝑇𝑖 is a treatment indicator (𝑇𝑖 = 1 if treatment, 𝑇𝑖 = 0 if control), 
𝛽𝑖 the individual treatment effect for patient 𝑖, and the 𝑥’s are observed or unobserved other linear 
causes of the outcome. By averaging the effects in both treatment (T) and control (C) group and 
subtracting the means one obtains an estimate for the ATE 
?̅?𝑇 −  ?̅?𝐶 = ?̅?𝑇 + ∑ 𝛾𝑗(?̅?𝑇𝑖𝑗 − ?̅?𝐶𝑖𝑗)
𝐽
𝑗=1
  (ATE) 
The major interest in conducting a RCT is on ?̅?𝑇 which is the true ATE in case that the averages of the 
other causes are exactly balanced between both groups. Bunge claims that the aim of randomization is 
to bring the error term on the right-hand side of the (ATE) equation as close to zero as possible. 
However, this is not what any RCT can guarantee [24,26]. What randomization actually does is 
guaranteeing that the error term is zero only in expectation. The expectation refers to an infinite 
number of repeated randomizations of the trial sample into treatment and control group – for an 
individual randomization the estimated ATE can be arbitrarily far away from the true ATE. Repeating 
the trial and estimating the ATE many times allows one to estimate a mean ATE and its standard error 
– this is the true benefit of randomization. Contrary to what Bunge claims, therefore, randomization 
will not guarantee that an individual RCT will provide us with an estimate of the ATE that is close to 
the truth. Instead, if there is background knowledge about the main other causes of the outcome one 
would be better of matching patients according to these other causes without randomization. But 
background knowledge is exactly what is omitted by Bunge when he proposes RCTs as the gold 
standard of clinical trials. Deaton and Cartwright put it this way: 
The gold standard or “truth” view does harm when it undermines the obligation of science to 
reconcile RCTs results with other evidence in a process of cumulative understanding. 
The conception of patients as open systems forces us to accept that we can never infer the true 
effect of a treatment through RCTs, even if we would be able to repeat one and the same trial an 
infinite number of times. The reason is that in each repetition, some changes in the environment or 
context in which the RCT is conducted are unavoidable. The best we can therefore do is to seek higher 
and higher confirmation for our hypotheses and determine their evidence against realistic competing 
hypotheses. But these goals are achievable by collecting relevant data across a variety of study types 
of both statistical and mechanistic character. A famous example is the establishment of the hypothesis 
that smoking causes lung cancer that was based on observational and laboratory data, but not on 
RCTs. Surprisingly, Bunge himself has used this example in one of his previous papers [16]: 
For example, since the mid-20th century, it has been known that lung cancer and smoking 
are strongly correlated, but only laboratory experiments on the action of nicotine and tar on 
living tissue have succeeded in testing (and confirming) the hypothesis that there is a definite 
causal link underneath the statistical correlation: we now know definitely that smoking may 
cause lung cancer. 
Note that for Bunge it was knowledge of the mechanisms that confirmed the hypothesis that 
smoking causes lung cancer. However, on our account, the strong correlational data between smoking 
                                                             
13 Actually, the very significance of knowing the average treatment effect for medical practice may be questioned. 
See Subramanian et al. [56] for a brief commentary.   
and lung cancer on its own provided a strong degree of confirmation for the hypothesis that smoking 
causes lung cancer. Knowing the mechanism regarding how smoking may cause lung cancer provided 
an additional, independent confirmation of this hypothesis so that the total confirmation became higher 
than with either the statistical or mechanistic data alone.
14
 However, causation was not established by 
the observational studies alone since the data they provided for a direct causal relationship between 
smoking and lung cancer was interpreted as not providing strong enough evidence compared to 
alternatives such as a “smoking gene” increasing both the tendency to smoke and to develop lung 
cancer.
15
 Only by knowing the carcinogenic mechanisms of tar and nicotine directly linking smoking 
and lung tumorigenesis was the observed correlation to be interpreted as strong data that smoking 
directly causes lung cancer instead of both being due to some third factor. Given our likelihood-based 
account of evidence, which must be comparative, we have three possible ways to compare two 
hypotheses. One could be a comparison between a causal hypothesis and a statistical hypothesis. The 
second could be a comparison between a causal hypothesis with another causal hypothesis. The third 
and final one could be between a statistical and another statistical hypothesis. The current scenario is 
concerned with case one in which a comparison is made between a causal hypothesis and a non-causal 
statistical hypothesis. Given the accumulated data regarding several observational studies on the 
proportion of tar in tobacco, the hypothesis that smoking causes cancer was supported more strongly 
than the hypothesis that smoking and cancer were merely correlated without implying any causal 
connection between them. This evidential relationship between the hypotheses, smoking causes 
cancer, and smoking and cancer are statistically related, given the data, holds independent of what an 
agent believes about those hypotheses and data. Therefore, from the basis of our account of evidence, 
we could say that data provide strong evidential support for the hypothesis that smoking causes cancer 
as against its alternative. So, from the perspectives of both accounts of evidence and confirmation, the 
hypothesis “smoking causes cancer” is more evidentially supported by data than its alternative 
hypothesis as well as it is strongly confirmed. This both-way vindication is possible because of the 
theorem: If two hypotheses are mutually exclusive and jointly exhaustive as well as simple statistical 
hypotheses, then data will provide evidential support for a hypothesis over its alternative if and only if 
data will confirm the hypothesis to some degree: 
[Pr(D|H)/Pr(D|¬H)] > 1 iff Pr(H|D) > Pr(H). 
Another example, also mentioned by Bunge himself [1, p. 147], is appendectomy to treat 
appendicitis. In this case, conducting a RCT with a control group receiving sham operation would not 
only be unethical, but also not necessary to highly confirm the hypothesis that appendectomy is an 
effective treatment. The reason is that the mechanism (infection of the appendix) and the way to shut it 
down (by removing the appendix) are very well known. This example is noteworthy since it could 
serve to illustrate that a causal hypothesis may be established by knowledge of mechanisms alone 
without the necessity for statistical data.
16
 A third example is the treatment of the rare disease glucose 
transporter 1 (GLUT1) deficiency syndrome through prescribing a high-fat low carbohydrate 
ketogenic diet: despite only “low level” clinical evidence available, a recent consensus guideline 
recommends ketogenic diets as the treatment of choice for GLUT1 deficiency syndrome mainly based 
                                                             
14 This is a consequence of the so-called “variety-of-evidence thesis” [42,43]. On our account, this is a slight 
misnomer. We call this the “variety-of-data thesis”. 
15 See chapter 5 in Judea Pearl’s “Book of Why” [57] for a detailed historical summary on how causation between 
smoking and lung cancer became established, including the argument that a “smoking gene” might be the 
underlying confounding factor.   
16 The example is a counter-example to the Russo-Williamson thesis according to which both statistical and 
mechanistic evidence is required to establish a causal claim [58]. See also Claveau [59] for another counter-
example to the Russo-Williamson thesis from the social sciences. 
on the physiological mechanism that ketone bodies are able to cross the blood-brain barrier 
independent from GLUT1, providing an alternative fuel for the brain instead of glucose [39].
17
 
As these examples show, RCTs are neither necessary nor sufficient for determining whether some 
factors cause a disease or an intervention is effective. Rather, causal claims may be established based 
on a variety of data from mechanistic, observational and other study types that conventionally sit 
below RCTs in the “evidence hierarchy”. We note that the difference between mechanistic and 
statistical (or probabilistic) data is not one between qualitative and quantitative data, nor one between 
observations stemming from laboratory versus clinical studies. In fact, mechanistic hypothesis may be 
framed as statistical models and applied to clinical data. For example, in radiotherapy mathematical 
models describing the mechanisms of cell killing through DNA damage caused by ionizing radiation 
are frequently utilized. They may be used clinically to convert between different fractionation schemes 
having the same biological effect or for predicting radiotherapy outcomes such as tumor control and 
normal tissue complication probability [40,41]. In our interpretation, the main distinction between 
mechanistic and statistical data is that the former can explain why the latter are observed. In the 
radiotherapy example, the mechanism itself is stochastic as it describes the killing of cells which obeys 
statistical laws; however, it also explains why higher radiation doses result in higher probability of 
tumor control, and even allows the derivation of the mathematical form of the dose-response 
relationship [40].  
Each causal claim has both probabilistic and mechanistic consequences that may be observed or 
not. Therefore, either mechanistic or statistical data are able to confirm a causal claim to some degree, 
whereas data from both sources provide even stronger confirmation according to the “variety-of-
evidence thesis” [42,43]. Mechanisms can also serve as background knowledge to increase the 
evidence of a causal hypothesis over a merely statistical one; this was the case in the smoking and lung 
cancer example. Finally, the optimal methodology for establishing a causal claim may depend on the 
exact type of hypothesis posed, e.g., the claim that an intervention worked in some setting versus the 
claim that it works for a particular patients, or a claim about a harmful effect [28]. 
4.3. RCTs and background knowledge 
For any researcher, prior or background knowledge plays a crucial role for the evaluation of 
causal hypotheses. This is naturally captured in our account of evidence and confirmation described in 
section 4.1, but not in Bunge’s account relying on RCTs as necessary methods for hypothesis testing. 
Andrew Gelman [44] has pointed out that using tools such as randomization and p-values to enforce 
scientific rigor misses the most important point of causal inferences, which is interpreting and 
understanding the results within the context of background knowledge. RCTs are not designed to rely 
on background knowledge which “is an advantage when persuading distrustful audiences, but it is a 
disadvantage for cumulative scientific progress, where prior knowledge should be built upon, not 
discarded” [27]. Thus, demanding the conduct of a RCT as a necessary condition for confirming a 
causal hypothesis, as Bunge does, violates his own postulates (S4) and (S5), because it discourages 
grouping hypotheses into medical theories and makes only minimal assumptions about the validity of 
other benchmark items, i.e., background knowledge. Judea Pearl has emphasized that if an agent is 
able to use her background knowledge in order to frame a causal model of reality, RCTs are no longer 
the only means to estimate the effect of interventions. In this case observational studies can do just as 
good with two additional advantages: their conduction is often more practical, and they study 
populations in their natural environment, instead of an artificial environments created by experimental 
                                                             
17  Ketone bodies are produced under conditions of low insulin levels such as during fasting or very low 
carbohydrate intake; in this respect, ketogenic diets can mimic fasting without necessarily restricting energy 
intake. Ketone bodies are transported through the blood-brain barrier by monocarboxylate transporters; this 
transport mechanism is therefore completely insulin- and GLUT-independent.  
protocols [45]. It is also well known that RCTs are not immune to bias, so that poorly designed RCTs 
may provide less certain results than well designed observational studies [27]. Background knowledge 
of the structure and mechanisms in the system under study is also important for meaningfully 
interpreting RCT results, or generally results from any statistical study. Deaton and Cartwright 
illustrate this using Bertrand Russel’s famous chicken example [27, p.11]: 
The bird infers, on repeated evidence, that when the farmer comes in the morning, he feeds 
her. The inference serves her well until Christmas morning, when he wrings her neck and 
serves her for dinner. Though this chicken did not base her inference on an RCT, had we 
constructed one for her, we would have obtained the same result that she did. Her problem 
was not her methodology, but rather that she did not understand the social and economic 
structure that gave rise to the causal relations that she observed. 
The importance of taking background knowledge into account also arises each time that results 
are discordant either between individual RCTs or between a RCT and another study type. From a 
purely empiricist standpoint ignoring what we know about the interplay between an intervention, the 
context under which it is applied and its mechanisms, such discrepancies are usually explained by 
invoking certain quality criteria based on design and statistical arguments [46]. For example, if there is 
discrepancy between RTCs and observational studies, results from the former are usually taken to 
“override” results from the latter. However, acknowledging that observing an intervention effect 
presupposes some mechanisms at work whose activation in turn may be context-dependent opens up 
much more possibilities for interpreting negative study results or discrepancies between study types. In 
particular, studies investigating an intervention may vary in context, in the mechanism that is exerted, 
or in both simultaneously [46]. An example for the latter situation is the supplementation of 
antioxidant vitamins for preventing cardiovascular disease which have been declared ineffective based 
on mostly negative findings in RCTs, although evidence from observational studies showed preventive 
effects. Connelly [46] emphasizes the realist standpoint that different antioxidant vitamins may act via 
different mechanisms that in turn may depend on the age of an individual and whose effects may only 
be observed over much longer follow-up periods than usually used in RCTs. He concludes:  
It seems that an alternative realistic perspective on this question [whether antioxidant 
vitamins can prevent cardiovascular disease] is again ignored in favour of what purports to 
be an unassailable scientific observation of the results from RCTs. Here, once more, the 
effect of ignoring differences in mechanisms and contexts may be to close down research in 
this area prematurely. 
By claiming that only RCTs can establish or not establish the efficacy of medical interventions, 
both Bunge and EBM discourage realist thinking about mechanisms and contexts whenever RCT 
results are available. As the antioxidant example shows, such thinking may preclude scientific 
progress, especially when interventions and effects are related via complex mechanisms. This is 
despite EBM explicitly stating the importance of evaluating “the totality of evidence” as one of its 
epistemological principles [19]. Maybe this is also the reason why Bunge downgrades complementary 
and alternative medicine (CAM) as “unscientific”, because by its very nature CAM works with 
complex interventions differently from simple drug administrations for which an evidence hierarchy 
with RCTs on top appears inadequate [29]. While for Bunge mechanisms are essential for 
understanding empirical phenomena through what he calls mechanismic explanation [16], he restricts 
their main epistemological role within the context of scientific medicine to “boosting” the 
confirmation of causal hypotheses provided by RCTs – in fact, no mention is made in his book how 
mechanisms may be used in conjunction with methodologies other than RCTs. In our opinion, this 
underestimates the role mechanisms should play in medical hypothesis testing and treatment design. 
As the examples of appendectomy and GLUT1 deficiency syndrome given in subsection 4.2 show 
there are situations where data of mechanisms become equally or more important than statistical data 
for establishing a causal claim of treatment efficacy. 
As another example, consider the establishment of a causal relationship between benzo[a]pyrene 
exposure and carcinogenesis in humans despite a lack of clinical data. Wilde and Parkkinen [47] have 
argued that one is justified in believing that benzo[a]pyrene causes cancer in humans because animal 
studies have provided evidence for both the robustness of the causal association and the mechanisms 
at work. In this example, knowledge of mechanisms provides the basis for the extrapolation of study 
results across different contexts, or more generally for building a causal theory that can then be applied 
to varying contexts. Such a theory resting on mechanismic explanation is much more flexible than 
individual hypotheses. In particular, predictions can be made from one context to another. At the same 
time, once particular mechanisms have confirmed a causal theory, “we should attempt to eliminate 
alternative explanations by testing the potential effects of these mechanisms, particularly in contexts 
other than the one where the theory was created” [48]. In other words, we should try to establish 
evidence that the mechanisms that are part of our theory are at work across a variety of contexts. To 
this aim, even case studies are valuable tools because they usually study individuals within more 
natural environments different from the ones artificially created by clinical study protocols and at the 
same time perform more thorough measurements than epidemiological studies. 
5. Conclusions 
Mario Bunge has provided a unique treatise of the philosophy of medicine which is based on a 
realist-systemic ontology. In Bunge’s view, the world consists of systems, which in turn consist of 
components, structures, mechanisms and an environment. These four constituents should be taken into 
account when studying any individual system. Bunge supports the methodology of EBM which 
considers RCTs to possess the most rigorous study design and to provide the best evidence for 
establishing the truth of causal hypotheses. Both Bunge and EBM thereby adopt a Humean view of 
causality in which causes and effects are constant conjunctions of events which in Bunge’s ontology 
are mediated through mechanisms. However, as we have argued in this paper, the view of RCTs as the 
best or even the only methodology for achieving knowledge about the efficacy of medical 
interventions is incompatible with a realist-systemic ontology. The reason is that the Humean view of 
causality only holds in closed systems, but patients and study populations are heterogonous open 
systems, and even the most rigorously conducted RCTs cannot guarantee closure of the system under 
study. This implies that the Humean view of causality cannot be sustained in medicine. Hence, 
Bunge’s claim that RCTs are necessary to establish the truth of the efficacy of an intervention must be 
rejected. 
Another consequence of the failure of Bunge’s and EBM’s Humean view of causality is that we 
need a probabilistic account of both evidence and confirmation. We have provided such accounts in 
this paper, building on the subjective Bayesian concept of confirmation and the objective concept of a 
likelihood ratio or Bayes factor to compare two competing hypotheses. Our Bayesian account of 
evidence is compatible with a realist-systemic ontology insofar as evidence is conceived as an 
objective function of the data generating process, which takes place via observed or unobserved 
mechanisms within the system under study. Finally, we maintain that Bunge’s general critique of 
Bayesianism is based on wrong interpretations of central concepts of probability, as the AIDS example 
discussed in section 4.1 has shown. 
We agree with Bunge that statistical data alone are not sufficient for causal reasoning; instead, 
what is needed is a causal hypothesis or causal model which can only be arrived at by thinking about 
structures and mechanisms. However, Bunge must accept the critique of overrating the merits of RCTs 
since he fails to account for the epistemological role of both already established mechanisms and 
statistical associations observed in different contexts. In fact, the environment which determines 
whether causal effects will emerge or not, is almost completely neglected in his account of medical 
hypothesis testing. His conception of an evidence hierarchy is at best unnecessary, at worst however 
an obstacle to scientific progress in the design and evaluation of medical treatments for individual 
patients. An analogous proposition applies to EBM with its various forms of methodological 
hierarchies [28]. The role of background knowledge of both mechanisms and the stability of statistical 
regularities across various contexts must be taken into account, which requires a variety of research 
methodologies. For example, critical realism, which has an ontology similar to Bunge’s systemism18, 
embraces a multitude of methodologies co-existing along each other, with no particular general 
preference for one methodology over any other [49,50]. We, along with an increasing number of 
critical philosophers and medical methodologists [30], encourage a similar approach in medicine, 
where “[t]he important point is not whether a study is randomized or not, but whether it uses a method 
well suited to answer a question and whether it implements this method with optimal scientific rigor” 
[29, p.5]. This implies considering results from preclinical and theoretical modelling studies, non-
randomized cohort studies, observational and case studies along with those from RCTs (if available) in 
an integrated or “circular” [29] rather than dogmatic-hierarchical framework, evaluating evidence 
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